There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

Zizyphi spinosi semen demonstrates neuroprotective effects, improving cognitive function and reducing amyloid and tau pathology in models of aging and dementia.

Early initiation of pimavanserin among patients with Parkinson disease psychosis were more likely to experience complete symptom resolution.

A new study published in the Journal of American Medical Association showed that hearing loss may indicate early ...

Neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, and amyotrophic lateral sclerosis (ALS), pose profound challenges in healthcare due to their progressive neuronal deterioration, which ...

Parkinson’s disease (PD ... Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including ...

Doctors in India are grappling to diagnose and treat unexplained and persistent symptoms of long Covid patients due to ...

Spanning nearly 100 laboratories in 45 countries, landmark research has, for the first time, shown an association between genetic brain size and neurological conditions such as Parkinson's disease ...

It gave me time back.” After years of development the U.S. Food and Drug Administration last week approved the Parkinson’s treatment for commercial use. It will not stop the progression of her ...

for adults living with advanced Parkinson's disease (PD). Vyalev is the first and only subcutaneous 24-hour continuous infusion of levodopa-based therapy for the treatment of motor fluctuations in ...